Evidence map›Paper›PMID 36254593›Full record

ArticleeLife2022

How should COVID-19 vaccines be distributed between the Global North and South: a discrete choice experiment in six European countries.

Janina I Steinert, Henrike Sternberg, Giuseppe A Veltri, Tim Büthe

Abstract read
In one paragraph

Article in eLife, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Janina I Steinert *Hochschule für Politik/Munich School of Politics and Public Policy, TUM School of Social Sciences & Technology and TUM School of Medicine, Technical University of Munich, Munich, Germany.ORCID 0000-0001-7120-0075
Henrike Sternberg *TUM School of Social Sciences & Technology, Technical University of Munich, Munich, Germany.ORCID 0000-0001-8539-6478
Giuseppe A VeltriDepartment of Sociology and Social Research, University of Trento, Trento, Italy.ORCID 0000-0002-9472-2236
Tim BütheHochschule für Politik/Munich School of Politics and Public Policy and TUM School of Social Sciences & Technology, Munich, Germany.ORCID 0000-0002-4724-5000

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The global distribution of COVID-19 vaccinations remains highly unequal. We examine public preferences in six European countries regarding the allocation of COVID-19 vaccines between the Global South and Global North. Methods: We conducted online discrete choice experiments with adult participants in France (n=766), Germany (n=1964), Italy (n=767), Poland (n=670), Spain (n=925), and Sweden (n=938). Respondents were asked to decide which one of two candidates should receive the vaccine first. The candidates varied on four attributes: age, mortality risk, employment, and living in a low- or high-income country. We analysed the relevance of each attribute in allocation decisions using conditional logit regressions. Results: In all six countries, respondents prioritised candidates with a high mortality and infection risk, irrespective of whether the candidate lived in the respondent's own country. All else equal, respondents in Italy, France, Spain, and Sweden gave priority to a candidate from a low-income country, whereas German respondents were significantly more likely to choose the candidate from their own country. Female, younger, and more educated respondents were more favourable to an equitable vaccine distribution. Conclusions: Given these preferences for global solidarity, European governments should promote vaccine transfers to poorer world regions. Funding: Funding was provided by the European Union's Horizon H2020 research and innovation programme under grant agreement 101016233 (PERISCOPE).

Indexed as

COVID-19VaccinesAdultCOVID-19 VaccinesEuropeFemaleHumansVaccinationCOVID-19 VaccinesVaccinescovid-19epidemiologyglobal healthhealth equityvaccinationviruses

Identifiers

PMID36254593
PMCPMC9592081

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.